Research Article

The impact of COVID-19 pandemic on the diagnostic distribution in dermatology outpatient clinic

Volume: 6 Number: 1 April 30, 2022
TR EN

The impact of COVID-19 pandemic on the diagnostic distribution in dermatology outpatient clinic

Abstract

Objective The admission frequency of diseases, including dermatological diseases, has changed after the COVID-19 outbreak. The aim of this study was to evaluate the change in the diagnosis distribution of dermatology outpatient clinics during the COVID-19 outbreak by comparing it with the same period of the last year. Materials and Methods The International Codes of Diseases (ICD-10) categories and patient's diagnoses were evaluated before and after the pandemic. All patients, who applied to the dermatology outpatient clinic between June 1, 2020, and September 1, 2020, were included in our study. This information was compared with the same period of the previous year. Results The hospital admissions were found reduced by 42.6%. The ratio of the patients with dermatophytosis, anogenital warts, scabies, seborrheic keratosis, urticaria, and xerosis cutis was significantly increased (p < 0.05), while the ratio of patients with actinic keratosis, callosities and corns, allergic contact dermatitis, lichen simplex, melasma, mycosis fungoides, nail disorders, nevi, prurigo nodularis, pruritus, psoriasis, and warts were significantly decreased after the COVID-19 pandemic (p < 0.05). Conclusions This is the first study on the frequency and most common types of outpatient dermatology visits, during the period of restriction reduction 3-6 months after the coronavirus pandemic. Many factors such as restrictions and hygiene practices, that affecting the quality of life, may cause changes in the diagnostic distribution of dermatology.

Keywords

References

  1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet; 2020; 395:497–506.
  2. Turkish Republic Ministry of Health. New Coronavirus Disease (COVID-19). Turkish Republic Ministry of Health. April 6, 2020. https://covid19bilgi.saglik.gov.tr/tr. Accessed April 7, 2020.
  3. Gupta M, Abdelmaksuoud A, Jafferany M, Lotti T, Sadoughifar R, Goldust M. COVID-19, and economy. Dermatol Ther. 2020 Jul;33(4): e13329. doi: 10.1111/dth.13329.
  4. Białynicki-Birula R, Siemasz I, Otlewska A, Łukasz Matusiak, Jacek C Szepietowski. Influence of COVID-19 pandemic on hospitalizations at the tertiary dermatology department in south-West Poland. Dermatol Ther. 2020 Jul;33(4): e13738. doi: 10.1111/dth.13738.
  5. Gisondi P, Piaserico S, Conti A, Naldi L. Dermatologists, and SARS‐CoV‐2: The impact of the pandemic on daily practice. J Eur Acad Dermatol Venereol. 2020; 34:1196-201.
  6. Ni MY, Yang L, Leung CM, Li N, Yao XI, Wang Y, et al. Mental health, risk factors, and social media use during the COVID-19 epidemic and cordon sanitaire among the community and health professionals in Wuhan, China: Cross-sectional survey. JMIR Ment Health 2020;7: e19009.
  7. Ozamiz-Etxebarria N, Dosil-Santamaria M, Picaza-Gorrochategui M, Idoiaga- Mondragon N. Stress, anxiety, and depression levels in the initial stage of the COVID-19 outbreak in a population sample in northern Spain. Cad Saude Publica 2020;36: e00054020.
  8. Kutlu Ö, Metin A. A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: will cases of psoriasis increase after COVID-19 pandemic? Dermatol Ther. 2020 Jul;33(4): e13383. doi: 10.1111/dth.13383.

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Research Article

Publication Date

April 30, 2022

Submission Date

December 19, 2021

Acceptance Date

April 3, 2022

Published in Issue

Year 2022 Volume: 6 Number: 1

APA
Coşansu, N. C., Yaldız, M., Sevimli Dikicier, B., & Erkorkmaz, Ü. (2022). The impact of COVID-19 pandemic on the diagnostic distribution in dermatology outpatient clinic. Journal of Biotechnology and Strategic Health Research, 6(1), 34-40. https://doi.org/10.34084/bshr.1038404
AMA
1.Coşansu NC, Yaldız M, Sevimli Dikicier B, Erkorkmaz Ü. The impact of COVID-19 pandemic on the diagnostic distribution in dermatology outpatient clinic. J Biotechnol and Strategic Health Res. 2022;6(1):34-40. doi:10.34084/bshr.1038404
Chicago
Coşansu, Nur Cihan, Mahizer Yaldız, Bahar Sevimli Dikicier, and Ünal Erkorkmaz. 2022. “The Impact of COVID-19 Pandemic on the Diagnostic Distribution in Dermatology Outpatient Clinic”. Journal of Biotechnology and Strategic Health Research 6 (1): 34-40. https://doi.org/10.34084/bshr.1038404.
EndNote
Coşansu NC, Yaldız M, Sevimli Dikicier B, Erkorkmaz Ü (April 1, 2022) The impact of COVID-19 pandemic on the diagnostic distribution in dermatology outpatient clinic. Journal of Biotechnology and Strategic Health Research 6 1 34–40.
IEEE
[1]N. C. Coşansu, M. Yaldız, B. Sevimli Dikicier, and Ü. Erkorkmaz, “The impact of COVID-19 pandemic on the diagnostic distribution in dermatology outpatient clinic”, J Biotechnol and Strategic Health Res, vol. 6, no. 1, pp. 34–40, Apr. 2022, doi: 10.34084/bshr.1038404.
ISNAD
Coşansu, Nur Cihan - Yaldız, Mahizer - Sevimli Dikicier, Bahar - Erkorkmaz, Ünal. “The Impact of COVID-19 Pandemic on the Diagnostic Distribution in Dermatology Outpatient Clinic”. Journal of Biotechnology and Strategic Health Research 6/1 (April 1, 2022): 34-40. https://doi.org/10.34084/bshr.1038404.
JAMA
1.Coşansu NC, Yaldız M, Sevimli Dikicier B, Erkorkmaz Ü. The impact of COVID-19 pandemic on the diagnostic distribution in dermatology outpatient clinic. J Biotechnol and Strategic Health Res. 2022;6:34–40.
MLA
Coşansu, Nur Cihan, et al. “The Impact of COVID-19 Pandemic on the Diagnostic Distribution in Dermatology Outpatient Clinic”. Journal of Biotechnology and Strategic Health Research, vol. 6, no. 1, Apr. 2022, pp. 34-40, doi:10.34084/bshr.1038404.
Vancouver
1.Nur Cihan Coşansu, Mahizer Yaldız, Bahar Sevimli Dikicier, Ünal Erkorkmaz. The impact of COVID-19 pandemic on the diagnostic distribution in dermatology outpatient clinic. J Biotechnol and Strategic Health Res. 2022 Apr. 1;6(1):34-40. doi:10.34084/bshr.1038404

Cited By

Journal of Biotechnology and Strategic Health Research